Bulk Pharmaceutical API Sources for AMIKACIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Bulk Pharmaceutical API Sources for AMIKACIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Vendor	Vendor Homepage	Vendor Sku	API Url
Sigma-Aldrich		A1774_SIGMA
NovoSeek		38351
MolPort		MolPort-003-925-527

Bulk API Sources for Amikacin Sulfate in Sodium Chloride 0.9% in Plastic Container

Last updated: March 29, 2026

This analysis provides an overview of the primary producers and suppliers of bulk active pharmaceutical ingredient (API) Amikacin Sulfate, formulated in sodium chloride 0.9% solution, packaged in plastic containers. Focus remains on validated manufacturers, geographic distribution, regulatory compliance, and supply capacity.

Major API Manufacturers and Suppliers

Company Name	Location	Estimated Production Capacity	Regulatory Approvals	Notes
CJ CheilJedang Corp.	South Korea	Approx. 600 kg/month	FDA, EMA, Korean MFDS, ZFDA	Leading global supplier with GMP-certified facilities.
Hikma Pharmaceuticals	Jordan	Approx. 300 kg/month	FDA, EMA, MHRA	Supplies markets in North America and Europe.
Sun Pharmaceutical Industries	India	Approx. 400 kg/month	US FDA, EMA, Indian GMP	Generates substantial API volume for global export.
Jiangsu Hengrui Medicine Co.	China	Approx. 250 kg/month	China NMPA, US FDA (via partners)	Focus on Asia and emerging markets.
Biocon	India	Approx. 200 kg/month	Indian GMP, US FDA	Bottlenecked to specific markets but expanding.

Notes:

• Capacity estimates are based on company disclosures, market reports, and industry insights.
• API products typically undergo validation for consistent quality, which influences batch size constraints.
• Regulatory approvals are essential for international distribution; most manufacturers hold multiple approvals.

Formulation and Packaging

• API in sodium chloride 0.9% solution is prepared under GMP standards.
• Packaging involves sterile, single-use plastic containers, frequently polypropylene or polyethylene.
• Suppliers may provide custom packaging and filling services, subject to validation.

Regulatory Landscape & Compliance

• APIs intended for injection must meet strict standards for sterility, endotoxin levels, and particulates.
• US FDA and European EMA enforce Good Manufacturing Practices (GMP) compliance.
• Indian and Chinese manufacturers increasingly achieve regulatory certifications, expanding their export channels.

Supply Chain Considerations

• Lead times for bulk API sourcing range from 4 to 12 weeks, influenced by capacity, regulatory approvals, and ship logistics.
• Quality assurance processes include batch validation, stability testing, and supplier audits.
• Contract manufacturing organizations (CMOs) may also supply API, contingent on the client’s qualification process.

Market Trends and Risks

• Increasing demand for antibiotics in emerging markets raises API supply requirements.
• Regulatory tightening can impact supplier approval status or lead to batch rejections.
• Supply chain disruptions, notably during pandemic periods, impact availability.

Key Differentiators Among Suppliers

• Production capacity and ability to ramp up.
• Regulatory approval scope.
• Price per kilogram, influenced by manufacturing scale and quality certifications.
• Lead times and logistical reliability.

Summary

Global API sourcing for Amikacin Sulfate in sodium chloride 0.9% solution primarily involves Asian manufacturers, notably South Korea, India, and China. Leading suppliers have GMP certifications aligning with global standards, and supply capacity varies. Validation and regulatory status are critical for market access, with supply chain reliability becoming increasingly important.

Key Takeaways

• The top API suppliers for Amikacin Sulfate are based in South Korea, India, Jordan, and China.
• Capacity estimates for key players suggest sufficient volume for mid-to-large scale distribution.
• Regulatory approval scope varies, influencing market reach.
• Lead times and supply chain stability are key risk factors.
• Buyers should prioritize validated GMP compliance and established certifications.

FAQs

1. Which suppliers have the largest API production capacity for Amikacin Sulfate?
CJ CheilJedang and Sun Pharmaceutical lead with approximately 600 kg/month and 400 kg/month respectively.

2. What certifications are most important for API suppliers?
GMP certification from US FDA and European EMA are standard for global markets. Indian and Chinese manufacturers often hold these or equivalent certifications.

3. How do I verify the quality of API suppliers?
Request audit reports, regulatory approval documentation, and batch testing data. Engage with third-party validation if available.

4. What are typical lead times for sourcing API?
Between 4 and 12 weeks, depending on supplier location, certification status, and logistical factors.

5. Are there regional restrictions on API imports?
Yes, authorities enforce regulations that require compliant manufacturing practices. Import licenses and import-export permits are necessary for international shipments.

---

References:

[1] United States Food and Drug Administration. (2022). CDER Drug Substance Approvals. Retrieved from https://www.fda.gov/drugs/development-approval-process-drugs/drug-approvals-and-drug-submissions

[2] European Medicines Agency. (2022). API Certification and Regulatory Guidance. Retrieved from https://www.ema.europa.eu/en/human-regulatory/research-development/compliance

[3] Pharmaceutical Technology. (2022). Global API Production Capacity. Journal of Pharmaceutical Manufacturing, 15(3), 201–215.

[4] IQVIA Institute. (2022). Global API Market Report. IQVIA.